Back to top
more

Pediatrix Medical Group, Inc. (MD)

(Delayed Data from NYSE)

$7.59 USD

7.59
1,515,466

+0.06 (0.80%)

Updated May 23, 2024 04:00 PM ET

After-Market: $7.60 +0.01 (0.13%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (87 out of 249)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for MD

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

0 items in cart

Pediatrix Medical Group, Inc. [MD]

Reports for Purchase

Showing records 201 - 220 ( 339 total )

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 201

10/30/2014

Daily Note

Pages: 3

Volumes Improve; Growth from M&A Decelerates

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 10.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 202

08/01/2014

Company Report

Pages: 7

2Q Beats by $0.01. 3Q14 Guidance In-Line. Outlook Remains Positive. Acquisitions, Parity Leverage Expected To Drive Earnings Growth. Affirm Buy Rating and $66PT.

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 203

07/31/2014

Company Report

Pages: 8

Mixed Quarter, but M&A Outlook Remains Strong

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 204

07/31/2014

Daily Note

Pages: 19

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Price: 50.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 205

07/31/2014

Daily Note

Pages: 3

Quick Alert: 2Q in Line as Revenue Growth Is Mostly Unchanged Q/Q

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 10.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 206

05/15/2014

Daily Note

Pages: 3

Discontinuation of Research Coverage

Provider: FELTL & COMPANY

Price: 10.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 207

05/05/2014

Company Report

Pages: 7

1Q Beats by $0.02. 2Q14 Guidance In-Line.

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 208

05/02/2014

Company Report

Pages: 6

Q1 results positive in tough environment

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: WASSERMAN R

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 209

05/02/2014

Company Report

Pages: 8

Mixed quarterly results and a full valuation keep us on the sidelines

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 210

05/01/2014

Daily Note

Pages: 19

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Price: 50.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 211

05/01/2014

Daily Note

Pages: 3

Quick Alert: 1Q EPS in Line, Despite Weak Organic Trends

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 10.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 212

05/01/2014

Company Report

Pages: 7

Roll-Up Opportunity Offsets Tough Organic Environment

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 213

04/29/2014

Company Report

Pages: 9

Preliminary low weight birth data suggests inline 1Q14 trends

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 214

02/03/2014

Company Report

Pages: 6

Raising rating to Buy on steadier outlook

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: WASSERMAN R

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 215

01/31/2014

Company Report

Pages: 8

Solid 4Q13 results with a bump from parity and rebound in NICU volumes

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 216

01/30/2014

Daily Note

Pages: 21

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Price: 75.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 217

01/30/2014

Company Report

Pages: 7

4Q Beats by $0.04. 1Q14 Guidance In-Line. Outlook Remains Positive. Acquisitions, Parity Leverage Expected To Drive Earnings Growth. Affirm Buy and $63 PT.

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 218

01/30/2014

Daily Note

Pages: 3

Quick Alert: 4Q EPS Ahead on Higher Parity Payments & Improved Volumes

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 10.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 219

01/30/2014

Company Report

Pages: 6

Parity Likely Offers Upside in 2014, but Potential Headwind in 2015

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 220

01/29/2014

Company Report

Pages: 9

4Q13 Preliminary low weight birth data implies improving trends

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party